On the efficiency of oral acetaminophen on artery closure among premature infants hospitalized in IC
Not Applicable
- Conditions
- Patent Ductus Arteriosus.Patent ductus arteriosus
- Registration Number
- IRCT2014122714333N26
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Inclusion: infants with contraindication using ibuprophen (oliguria: output less than 1cc/kg/hr. plackets less than 50000. Hyperbilirubinemia with the need to jaundice. Necrotizing enterocolitis perforation of the gastrointestinal tract); infants who were not treated through taking oral ibuprophen twice a day; infants with PDA determined by echocardiography. Exclusion: Congenital heart disease with the need to PDA to keep blood flow constant; life threatening infection; Intraventricular hemorrhage at 3 and 4 grades.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patent or closure of Ductus Arteriosus. Timepoint: By a doctor. Method of measurement: At the beginning of the intervention and three after that.
- Secondary Outcome Measures
Name Time Method